Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290

J. Jason McAnany, Mohamed A. Genead, Saloni Walia, Arlene V. Drack, Edwin M. Stone, Robert K. Koenekoop, Elias I. Traboulsi, Alison Smith, Richard Weleber, Samuel G. Jacobson, Gerald A. Fishman

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. Methods: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the bestcorrected VA at the initial and most recent visits, as well as the correlation between age and VA. Results: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had non-measurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P > .05). There was no significant relationship between VA and age. Conclusions: Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.

Original languageEnglish (US)
Pages (from-to)178-182
Number of pages5
JournalJAMA Ophthalmology
Volume131
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Leber Congenital Amaurosis
Visual Acuity
Mutation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

McAnany, J. J., Genead, M. A., Walia, S., Drack, A. V., Stone, E. M., Koenekoop, R. K., ... Fishman, G. A. (2013). Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290. JAMA Ophthalmology, 131(2), 178-182. https://doi.org/10.1001/2013.jamaophthalmol.354

Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290. / McAnany, J. Jason; Genead, Mohamed A.; Walia, Saloni; Drack, Arlene V.; Stone, Edwin M.; Koenekoop, Robert K.; Traboulsi, Elias I.; Smith, Alison; Weleber, Richard; Jacobson, Samuel G.; Fishman, Gerald A.

In: JAMA Ophthalmology, Vol. 131, No. 2, 02.2013, p. 178-182.

Research output: Contribution to journalArticle

McAnany, JJ, Genead, MA, Walia, S, Drack, AV, Stone, EM, Koenekoop, RK, Traboulsi, EI, Smith, A, Weleber, R, Jacobson, SG & Fishman, GA 2013, 'Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290', JAMA Ophthalmology, vol. 131, no. 2, pp. 178-182. https://doi.org/10.1001/2013.jamaophthalmol.354
McAnany, J. Jason ; Genead, Mohamed A. ; Walia, Saloni ; Drack, Arlene V. ; Stone, Edwin M. ; Koenekoop, Robert K. ; Traboulsi, Elias I. ; Smith, Alison ; Weleber, Richard ; Jacobson, Samuel G. ; Fishman, Gerald A. / Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290. In: JAMA Ophthalmology. 2013 ; Vol. 131, No. 2. pp. 178-182.
@article{7ca320fbc3804f90b90df62a80ec9b27,
title = "Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290",
abstract = "Objective: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. Methods: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the bestcorrected VA at the initial and most recent visits, as well as the correlation between age and VA. Results: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had non-measurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P > .05). There was no significant relationship between VA and age. Conclusions: Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.",
author = "McAnany, {J. Jason} and Genead, {Mohamed A.} and Saloni Walia and Drack, {Arlene V.} and Stone, {Edwin M.} and Koenekoop, {Robert K.} and Traboulsi, {Elias I.} and Alison Smith and Richard Weleber and Jacobson, {Samuel G.} and Fishman, {Gerald A.}",
year = "2013",
month = "2",
doi = "10.1001/2013.jamaophthalmol.354",
language = "English (US)",
volume = "131",
pages = "178--182",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290

AU - McAnany, J. Jason

AU - Genead, Mohamed A.

AU - Walia, Saloni

AU - Drack, Arlene V.

AU - Stone, Edwin M.

AU - Koenekoop, Robert K.

AU - Traboulsi, Elias I.

AU - Smith, Alison

AU - Weleber, Richard

AU - Jacobson, Samuel G.

AU - Fishman, Gerald A.

PY - 2013/2

Y1 - 2013/2

N2 - Objective: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. Methods: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the bestcorrected VA at the initial and most recent visits, as well as the correlation between age and VA. Results: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had non-measurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P > .05). There was no significant relationship between VA and age. Conclusions: Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.

AB - Objective: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. Methods: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the bestcorrected VA at the initial and most recent visits, as well as the correlation between age and VA. Results: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had non-measurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P > .05). There was no significant relationship between VA and age. Conclusions: Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.

UR - http://www.scopus.com/inward/record.url?scp=84874076775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874076775&partnerID=8YFLogxK

U2 - 10.1001/2013.jamaophthalmol.354

DO - 10.1001/2013.jamaophthalmol.354

M3 - Article

VL - 131

SP - 178

EP - 182

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 2

ER -